Searching for the Achilles' heel of melanoma cells: new treatment modalities.
Melnikova
Vladislava O
VO
Bar-Eli
Menashe
M
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D001557:Benzenesulfonates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009536:Niacinamide / Q000031:analogs & derivatives; D016566:Organoselenium Compounds / Q000627:therapeutic use; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000077157:Sorafenib; D016896:Treatment Outcome; D014508:Urea / Q000031:analogs & derivatives / Q000627:therapeutic use; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D004791:Enzyme Inhibitors; D005493:Folic Acid Antagonists; D016566:Organoselenium Compounds; D010671:Phenylurea Compounds; D011725:Pyridines; C530804:S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea; D009536:Niacinamide; D014508:Urea; D000077157:Sorafenib; D040301:Vascular Endothelial Growth Factor Receptor-2; D011739:Pyrimethamine